ABUS vs ADI · P/E 5.4, rev $6.2M vs P/E 61, rev $11.02B
Arbutus Biopharma Corp (ABUS) versus Analog Devices Inc (ADI) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Not investment advice. Open the ABUS and ADI stock pages for the full models.
Not investment advice.